![Great things happen when industry leaders and particles collide – Moffitt Cancer Center](https://oncodaily.com/pub/uploads/2025/02/image-2-12-e1739376053709.png)
Great things happen when industry leaders and particles collide – Moffitt Cancer Center
Moffitt Cancer Center shared a post on LinkedIn:
“Great things happen when industry leaders and particles collide!
Our Moffitt delegation received a warm welcome today from our friends at IBA Proton Therapy in Belgium.
As the world leader in particle accelerator technology, IBA is bringing its groundbreaking ProteusONE to the Tampa Bay Area. Proton therapy is the most advanced cancer-killing technology in the world.
With Moffitt’s elite clinical expertise and IBA’s shared vision for saving lives, proton therapy will be a game changer. Excited for groundbreaking discoveries and innovation with this amazing partner!”
Patrick Hwu, President and CEO at Moffitt Cancer Center, reshared the post on LinkedIn, adding:
Excited to be in Belgium, where our Moffitt Cancer Center team received a warm welcome from IBA at their headquarters!
We’re thrilled to have the world leader in particle accelerator technology bring their groundbreaking ProteusONE proton therapy unit to our SperosFL campus in Pasco County, Florida.
Through our partnership, we’ll save lives, enhance patient care, and advance cancer research!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023